Medx Health

Medx Health EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Medx Health (MDX.V) as of Oct 21, 2026 is -4.90. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -7.61 — a change of -35.62% (higher).

EV/FCF

-4.90

YoY

-35.62%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Medx Health is 2025 -4.90 . EV/FCF (Enterprise Value to Free Cash Flow) of Medx Health was 2024 -7.61 . It decreases by -35.62% higher compared to the previous year.

The Medx Health EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-7.09 CAD
Jan 1, 2019
-13.57 CAD
Jan 1, 2020
-6.27 CAD
Jan 1, 2021
-4.51 CAD
Jan 1, 2022
-6.72 CAD
Jan 1, 2023
-5.53 CAD
Jan 1, 2024
-7.61 CAD
Jan 1, 2025
-4.90 CAD
The Medx Health EV/FCF history
YEAREV/FCFYoY
-4.90-35.62%
-7.61+37.70%
-5.53-17.74%
-6.72+49.14%
-4.51-28.11%
-6.27-53.80%
-13.57+91.25%
-7.09-44.32%
-12.74-9.56%
-14.09-61.43%
-36.53+84.53%
-19.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? MedX Health Corp develops and sells medical devices and software focused on skin health. Its core products include SIAscopy technology for scanning skin moles and lesions, integrated with the DermSecure telemedicine platform. The company manufactures hand-held devices like SIAMETRICS, SIMSYS, and MoleMate, which use light-based technology to detect skin issues up to two millimeters beneath the surface without pain or invasion. These devices are used in dermatology clinics and rehabilitation centers for early skin cancer detection and non-invasive treatment of pain and tissue damage. The company's telemedicine platform, SIAscopy on DermSecure, enables remote operation of its scanning technology through web-based services. Phototherapy devices utilizing lower-level laser and LED light energy are sold to healthcare providers for pain relief and tissue repair in rehabilitation settings. The primary customers are dermatologists, clinics specializing in skin health, and rehabilitation facilities seeking non-invasive diagnostic and treatment solutions. MedX Health Corp generates revenue through direct sales of its medical devices, telemedicine software, and phototherapy equipment. The SIAscopy technology and associated products are marketed to healthcare professionals in the dermatology and rehabilitation sectors. The company's focus on skin screening and pain-free tissue repair drives sales of its hand-held devices and telemedicine platform to medical institutions requiring advanced diagnostic tools. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

EV/FCF (Enterprise Value to Free Cash Flow) of Medx Health is -4.90 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Medx Health changed from -7.61 to -4.90, representing a -35.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Medx Health since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Medx Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medx Health

All Key Metrics — Medx Health